A carregar...
Phase 0 Radiopharmaceutical–Agent Clinical Development
The evaluation of antibody-targeted or peptide-targeted radiopharmaceuticals as monotherapy or in oncological drug combinations requires programmatic collaboration within the National Cancer Institute (NCI) clinical trial enterprise. Phase 0 trials provide a flexible research platform for the study...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7461940/ https://ncbi.nlm.nih.gov/pubmed/33014772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01310 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|